⚡ Technology🌐 Global
FDA Advisors Vote Unanimously to Approve Moderna's mRNA Flu Vaccine After Months of Political Turmoil
Ars Technica·Monday, 22 June 2026
FDA advisory committee members voted unanimously to recommend approval of Moderna's mRNA-based vaccine after a Trump administration official refused to review it back in February. The unanimous vote comes after months of political interference at the agency. The final approval decision now rests with the FDA itself.
Why It Matters
mRNA vaccine technology is the same platform behind widely used COVID shots — its success or failure in new applications affects global vaccine development, including what eventually reaches India.
🔒 Potential Impact + source link
Subscribe to unlock the impact analysis and original source for every story.
More from Technology
- Google Confirms Android Developer Verification Rollout — What It Means for Your Apps
- New Malware Steals Crypto via USB Drives and Hides Behind Tor — Microsoft Warns
- Apple Fixes Year-Old Eavesdropping Bug in Beats Studio Buds — Multiple Brands Affected
- Taiwan Is Scaling Up Drone Production for Defense — and the US Military